MAPS Celebrates Submission of New Drug Application to FDA for MDMA-Assisted Therapy for PTSD
December 13, 2023 18:16 ET
|
Multidisciplinary Association for Psychedelic Studies (MAPS)
The first NDA submission for any psychedelic-assisted therapy has been submitted through a 30-year effort initiated and led by the nonprofit MAPS
United States Cosmetics Markets, Competition, Forecast & Opportunities, 2028F: E-Commerce Sales Surge, Increasing Consumer Spending, Surge in Preference for Natural, Cruelty-Free, and Organic Products
December 07, 2023 10:53 ET
|
Research and Markets
Dublin, Dec. 07, 2023 (GLOBE NEWSWIRE) -- The "United States Cosmetics Market Competition Forecast & Opportunities, 2028" report has been added to ResearchAndMarkets.com's offering.The United...
Global Life Science Analytics Software Market set to achieve a 12.5% CAGR, projected to attain USD 19,570 Million by 2030 as per Straits Research
November 30, 2023 10:30 ET
|
Straits Research
New York, United States, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Software for analysis conducts statistical and quantitative analysis. It generates and exports exploratory and predictive models for...
The Virtual Trip Showcases Veterans Sessions from Psychedelic Science 2023 in Honor of Veterans Day
November 11, 2023 01:46 ET
|
Multidisciplinary Association for Psychedelic Studies (MAPS)
Eight virtual conference sessions explore psychedelic research for Veterans including trauma support, federal backing, and a pilot study on Ibogaine
Pediatric PTSD: Neurobiology and Treatment - A Free Webinar from the Brain & Behavior Research Foundation
November 09, 2023 10:28 ET
|
Brain & Behavior Research Foundation
New York, Nov. 09, 2023 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “Pediatric PTSD: Neurobiology and Treatment” on Tuesday, November 14, 2023,...
World’s First Observational Trial to Assess Real-World Efficacy of MDMA Treatment
November 09, 2023 08:55 ET
|
PharmAla Biotech
PharmAla partners with Heroic Hearts Canada and the University of Calgary to launch the world's first observational rial into MDMA's real-world efficacy
Silo Pharma to Initiate Dose-Ranging Study of Novel Intranasal Therapeutic SPC-15 for the Treatment of PTSD
November 08, 2023 08:11 ET
|
Silo Pharma, Inc.
ENGLEWOOD CLIFFS, NJ, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“the Company”), a developmental stage biopharmaceutical company focused on merging traditional therapeutics...
PharmAla Completes Historic First Shipment of MDMA and Psilocybin to Cortexa
November 07, 2023 08:55 ET
|
PharmAla Biotech
PharmAla completes the historic first shipment of MDMA and Psilocybin to its Australian Joint Venture, Cortexa, for use in commercial patient treatments
Mydecine Provides Q4 2023 Business Update
October 26, 2023 02:00 ET
|
Mydecine Innovations Group Inc.
Mydecine is pleased to address its shareholders and provide a general update on the company's progress.
Scoliosis Braces Market Size is Expected to Reach $306 Million, with 4.5% of CAGR by 2030: Straits Research
October 19, 2023 15:40 ET
|
Straits Research
New York, United States, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Scoliosis is an abnormal curve in the spine that makes a person hunch over when they stand or walk. Scoliosis braces are the most common...